<qa>  What is the name of the trial that was conducted with levetiracetam?For ethical reasons to give opportunity for adult subjects 16 or 18 years suffering from newly diagnosed epilepsy who completed the therapeutic confirmatory, open-label trial N01175 NCT00175903 conducted with levetiracetam in monotherapy and who benefited from the treatment, to receive treatment with levetiracetam until the monotherapy indication for levetiracetam is granted in Europe. 